Morgan Stanley Ice Cure Medical Ltd. Put Options Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ICCM
# of Institutions
14Shares Held
154KCall Options Held
0Put Options Held
0-
Xtx Topco LTD London, X058.9KShares$86,5330.01% of portfolio
-
Geode Capital Management, LLC Boston, MA40.5KShares$59,4650.0% of portfolio
-
Two Sigma Securities, LLC New York, NY17KShares$24,9820.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny10.9KShares$16,0230.0% of portfolio
-
Concurrent Investment Advisors, LLC Tampa, FL10KShares$14,7000.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $54.1M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.